EP2886103A1 — Pharmaceutical orodispersible film comprising buprenorphine particles with a particular size
Assigned to Hexal AG · Expires 2015-06-24 · 11y expired
What this patent protects
The present invention relates to a pharmaceutical orodispersible film composition which comprises buprenorphine in the form of particles having a maximum particle diameter Dv90 of at most 20 micrometer, and the process of preparation thereof.
USPTO Abstract
The present invention relates to a pharmaceutical orodispersible film composition which comprises buprenorphine in the form of particles having a maximum particle diameter Dv90 of at most 20 micrometer, and the process of preparation thereof.
Drugs covered by this patent
- Subutex (Buprenorphine Hydrochloride) · Indivior
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.